Oxitec is pleased to congratulate Dr Luke Alphey on being shortlisted for the BBSRC’s Innovator of the Year competition, 2014. Shortlisted in the social innovator category, the award recognises Dr Alphey’s world-leading research at Oxitec in the field of genetic control of insect pests and the potential benefit to society.
The awards were established by the Biotechnology and Biological Sciences Research Council (BBSRC) in 2008. According the Minister for Universities and Science, David Willetts:
“These awards recognise the impact of bioscience both on the economy and society, through driving innovation, training highly-skilled people, improving businesses and public services and attracting foreign investment.”
Oxitec CEO Hadyn Parry said:
“I’m delighted to offer our congratulations to Luke on being shortlisted for this prestigious award. The BBSRC funds some of the world’s leading bioscientists, so for Luke to be chosen is a testament to the world class research he led while at Oxitec.
“For the past 10 years, Luke and Oxitec have been committed to translating that research into new and more effective, sustainable solutions to controlling the dengue mosquito and other insect pests; being shortlisted in the social innovator category is a wonderful endorsement of his scientific creativity and excellence. As a company we are proud of the work he initiated and are committed to fulfil the potential of this technology for the benefit of farmers and those live in areas blighted by mosquito borne diseases.
“We wish him the very best of luck at the awards ceremony.”
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Its aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, and with an annual budget of around £500M (2012-2013), it supports research and training in universities and strategically funded institutes. BBSRC research and the people it funds are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Its investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
About Oxitec Ltd.
Oxitec is a pioneer in controlling insects that spread disease and damage crops. Its products build upon the use of the Sterile Insect Technique (SIT), an effective, species-specific and environmentally friendly method of controlling harmful and damaging insects. Oxitec’s first products are for the control of Aedes aegypti, the mosquito species primarily responsible for transmitting dengue fever, and Mediterranean fruit fly, one of the world’s most damaging agricultural pests.
Website and social networks: